Monday, January 31, 2022

January 31, 2022 at 11:31PM cobas TaqScreen MPX Test, version 2.0

Product approval information for
•Direct detection of Human Immunodeficiency Virus Type 1 (HIV-1) Group M RNA, HIV-1 Group O RNA, Human Immunodeficiency Virus Type 2 (HIV-2) RNA, Hepatitis C Virus (HCV) RNA, and Hepatitis B Virus (HBV) DNA in human plasma.
•Simultaneous detection and discrimination of HIV RNA, HCV RNA, and HBV DNA.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/C1Td2tHl3

January 31, 2022 at 08:20PM Multilingual COVID-19 Resources

The U.S. Centers for Disease Control and Prevention (CDC), and international and U.S. Government partners including FDA, are addressing an outbreak of coronavirus disease 2019 (COVID-19).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/PlOt9NebH

January 31, 2022 at 07:49PM Cellular, Tissue and Gene Therapies Advisory Committee October 12, 2017 Meeting Announcement - 10/12/2017

This is the CBER Cellular, Tissue and Gene Therapies Advisory Committee October 12, 2017 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/e05DYZKLx

January 31, 2022 at 05:56PM Vaccines Licensed for Use in the United States

The product name and trade name of vaccines licensed for use in the United States.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/29JiMXYSa

January 31, 2022 at 05:55PM Licensed Biological Products with Supporting Documents

Licensed biological products with supporting documents is arranged alphabetically by the proper name of the product(s). Information is provided for original product approvals, new indications, and the current package insert.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/rnYjdQFJu

January 31, 2022 at 05:53PM SPIKEVAX

COVID19 Vaccine, mRNA

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/84bEhzPSg

January 31, 2022 at 05:32PM Coronavirus (COVID-19) Update: FDA Takes Key Action by Approving Second COVID-19 Vaccine

The FDA approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/QKFk2pG0i

January 31, 2022 at 04:55PM Spikevax and Moderna COVID-19 Vaccine

Information about the Moderna COVID-19 Vaccine and Spikevax

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/kgqlX3Ldo

Friday, January 28, 2022

January 29, 2022 at 03:41AM Laboratory Information Bulletins

Laboratory Information Bulletins available to the public

via Whats New Vaccines Blood Biologics RSS Feed https://bit.ly/3g702nq

January 28, 2022 at 07:09PM Meeting Materials, Vaccines and Related Biological Products Advisory Committee

These are the Meeting Materials for the Vaccines and Related Biological Products Advisory Committee

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2NbzINy

January 28, 2022 at 06:52PM Vaccines and Related Biological Products Advisory Committee March 3, 2022 Meeting Announcement - 03/03/2022

This is the CBER Vaccines and Related Biological Products Advisory Committee March 3, 2022 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/34cUxAK

January 28, 2022 at 06:45PM 2022 Meeting Materials, Vaccines and Related Biological Products Advisory Committee

This is the main page for the CBER 2022 Meeting Materials, Vaccines and Related Biological Products Advisory Committee (VRBPAC).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3Hb7oSJ

January 28, 2022 at 02:51PM Principles of Premarket Pathways for Combination Products

Final guidance for industry and FDA staff: Principles of Premarket Pathways for Combination Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/363DyNX

Thursday, January 27, 2022

January 27, 2022 at 01:30PM YESCARTA (axicabtagene ciloleucel)

YESCARTA is a treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including DLBCL not otherwise specified, primary mediastinal large B-cell lymphoma, high grade B-cell lymphoma, and DLBCL arising from follicular lymphoma.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2BbIKEt

January 27, 2022 at 07:08PM Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories

To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and UTMB collaborate to provide an annual training course on how to meet GLP requirements in BSL-4 facilities

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/30kpooc

January 27, 2022 at 05:09PM Questions about Blood

FDA is responsible for ensuring the safety of the Nation's blood supply. While a blood supply with zero risk of transmitting infectious disease may not be possible, there are several measures taken by FDA to protect and enhance the safety of blood products.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2EHp35H

Wednesday, January 26, 2022

January 26, 2022 at 08:49PM Premarket Approvals (PMAs) and Humanitarian Device Exemptions (HDEs)

List of Premarket Approvals (PMAs) and Humanitarian Device Exemptions (HDEs)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3G4Txvy

January 26, 2022 at 08:06PM Premarket Approval (PMA) for CBER-Regulated Products

Center for Biologics Evaluation and Research (CBER) regulates medical devices related to licensed blood and cellular products while applying appropriate medical device laws and regulations.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3u3Qzp4

January 25, 2022 at 02:48PM Patient Engagement in the Design and Conduct of Medical Device Clinical Studies

From Patient Engagement Advisory Committee recommendations, this draft guidance describes engagement of patient advisors in design and conduct of device trials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3AxhMS5

January 25, 2022 at 02:47PM Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation

Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3hDxl0o

January 24, 2022 at 10:01PM Biologics Guidances

This page displays links to Biologics Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2XbPMD6

January 24, 2022 at 09:48PM Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2022

This is the list of guidance topics CBER is considering for development during Calendar Year 2022

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3fVcRRq

January 24, 2022 at 07:51PM Donating Blood Questions and Answers

Suitability to donate blood depends on the donation not being injurious to the donor and the donated blood not being unnecessarily hazardous to the recipient. Questions and answers for individuals interested in donating blood.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2rg1uxL

January 24, 2022 at 07:38PM Cleared 510(k) Submissions with Supporting Documents

Listing of cleared 510(k) submissions with supporting documents. Information is reflected as of the clearance date.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/31iI5ce

January 21, 2022 at 10:47PM FDA Public Meeting: Identification of Concepts and Terminology for Multi-Component Biomarkers - 03/23/2022

The FDA Center for Drug Evaluation and Research and the FDA Biomarker Working Group will convene a virtual workshop on March 23-24, 1-3 PM (EST) entitled “Identification of Concepts and Terminology for Multi-Component Biomarkers”. The workshop is intended to develop multi-component biomarker concepts and terminology to identify areas of conceptual

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3qOXEYr

January 21, 2022 at 09:35PM COVID-19 Vaccine Safety Surveillance

This page describes the monitoring the safety of authorized COVID-19 vaccines through both passive and active safety surveillance systems.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3jwsGPE

January 21, 2022 at 09:09PM OraQuick ADVANCE Rapid HIV-1/2 Antibody Test

Added labeling claim for the detection of HIV-2 antibodies in oral fluid and a change in the name of the device to OraQuick ADVANCE Rapid HIV-1/2 Antibody Test

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2REdVho

January 21, 2022 at 08:56PM Collecting and Providing 702(b) Portions of FDA Official Samples

Collecting and Providing 702(b) Portions of FDA Official Samples - Questions and Answers

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3tVWP1M

Thursday, January 20, 2022

January 20, 2022 at 04:25PM Blood Grouping and Phenotyping Reagents

Blood Grouping and Phenotyping Reagents Main Page

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3fEfBme

January 19, 2022 at 07:47PM Patient Engagement & Regenerative Medicine: An FDA CBER Workshop for Patient Advocates - 05/06/2021

FDA is hosting a patient workshop on May 6, 2021. This workshop will bring together patients, caregivers, advocates, and other important stakeholders to discuss ways for patients and their advocates to work with FDA to help advance regenerative medicine for rare and genetic diseases.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3ID6qPx

January 19, 2022 at 05:54PM Blood Products Advisory Committee November 4, 2021 Meeting Announcement - 11/04/2021

This is the CBER Blood Products Advisory Committee November 4, 2021 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3Kq2F1p

January 18, 2022 at 03:31PM Substantially Equivalent 510(k) Device Information

Listing of 510(k) submissions

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2o1NEwR

January 18, 2022 at 03:29PM Approved Blood Products

Products that are regulated as Biologics License Applications (BLAs), New Drug Applications (NDAS), Premarket Approvals (PMAs), and 510(k)s.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3oCV0RY

January 18, 2022 at 03:27PM Industry (Biologics)

CBER’s Manufacturers Assistance and Technical Training Branch provides assistance and training to industry, including large and small manufacturers and trade associations, and to respond to requests for information regarding CBER policies and procedures.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2QSlekD

January 18, 2022 at 03:06PM Premarket Notification 510(k) Process for CBER-Regulated Products

CBER regulates medical devices related to licensed blood and cellular products while applying appropriate medical device laws and regulations.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3rwgCSG

Monday, January 17, 2022

January 18, 2022 at 04:15AM Identification of Concepts and Terminology for Multi-Component Biomarkers Workshop - 03/23/2020

A productive discussion on the development of a conceptual, hierarchical & specific set of terminology needs in the biomarker domain.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3Kj6K7A

Friday, January 14, 2022

January 14, 2022 at 08:33PM Clinical Investigator Inspection List L-P

Contains names, addresses, and other information gathered from inspections of clinical investigators (L-P) who have conducted studies with investigational new drugs or investigational devices reviewed by the Center for Biologics Evaluation and Research (CBER).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2lwzP8u

January 14, 2022 at 08:33PM Clinical Investigator Inspection List E-K

Contains names, addresses, and other information gathered from inspections of clinical investigators (E-K) who have conducted studies with investigational new drugs or investigational devices reviewed by the Center for Biologics Evaluation and Research (CBER).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ly2N7X

January 14, 2022 at 08:32PM Clinical Investigator Inspection List A-D

Contains names, addresses, and other information gathered from inspections of clinical investigators who have conducted studies with investigational new drugs or investigational devices reviewed by the Center for Biologics Evaluation and Research (CBER).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2lBv4KV

January 11, 2022 at 08:40PM Janssen COVID-19 Vaccine

Information about the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3FvvBRX

January 14, 2022 at 03:48PM Many Important Drugs Approved in 2021 as COVID-19 Pandemic Continues

CDER approved a wide variety of safe and effective new drug therapies in 2021 despite challenges brought on by the ongoing COVID-19 pandemic.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/34SBufp

Thursday, January 13, 2022

January 14, 2022 at 02:32AM 2022_01 Test Article FT 01

2022_01 Test Article some long description some long description.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3zWZqcO

Wednesday, January 12, 2022

January 12, 2022 at 08:21PM How do I request a Patient Listening Session?

Learn about how to request a Patient Listening Session with the FDA to share your experiences and perspectives.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2YRE4gR

Tuesday, January 11, 2022

January 11, 2022 at 08:35PM Acceptance Review for De Novo Classification Requests

This guidance discusses De Novo acceptance policies and procedures, Refuse to Accept principles, and the Acceptance Checklist for De Novo Requests.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3m4vmnr

January 11, 2022 at 07:28PM Exceptions and Alternative Procedures Approved Under 21 CFR 640.120

Title 21 Code of Federal Regulations 640.120(a) - The Director, Center for Biologics Evaluation and Research, may approve an exception or alternative procedures to any requirement in subchapter F (Biologics) of Chapter I (Parts 600 - 680) of title 21 of the Code of Federal Regulations regarding bloo

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ZCEYhG

January 11, 2022 at 05:45PM Safety & Availability (Biologics)

Important information about the safety and availability of biological products.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2YW9bE5

Monday, January 10, 2022

January 10, 2022 at 09:57PM Coronavirus (COVID-19) | CBER-Regulated Biologics

This page and the associated links provide information on guidance and advice relevant to the development of therapies to treat or prevent COVID-19, and contact information for developers seeking additional information or assistance.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3cPytLJ

January 10, 2022 at 09:47PM How to Report Product Problems and Complaints to the FDA

If you use a product regulated by the U.S. Food and Drug Administration and have an unexpected reaction or other problem, the FDA wants to hear from you. Learn how to report problems.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3GeyojL

January 10, 2022 at 05:57PM Avances para salvar vidas con sangre

Un oficial de la Oficina de Investigación y Revisión Hematológica de la FDA discute alentadoras tecnologías que incluyen el uso de sangre y productos sanguíneos, para extender la vida de los productos sanguíneos mediante el uso de la tecnología del DNA hasta una mejor combinación entre donantes y receptores.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3k8ukGl

January 10, 2022 at 04:51PM Advances in Saving Lives with Blood

An FDA official in the Office of Blood Research and Review discusses promising technologies involving blood and blood products, from extending the life of blood products to using DNA technology to better match donors and recipients.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2DOAsUC

January 10, 2022 at 03:16PM Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act

This guidance clarifies who should notify, what information to include, and how to notify FDA of shortages, during or in advance of a public health emergency



via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3neCJMl

Friday, January 7, 2022

January 07, 2022 at 11:03PM Investigational COVID-19 Convalescent Plasma

FDA plays a critical role in protecting the United States (U.S.) from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JRD7fD

January 07, 2022 at 09:45PM Blood Products Advisory Committee November 4, 2021 Meeting Announcement - 11/04/2021 - 11/04/2021

This is the CBER Blood Products Advisory Committee November 4, 2021 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3C5YdQn

January 07, 2022 at 09:43PM BEXSERO

Active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32K879h

January 07, 2022 at 08:25PM Vaccines and Related Biological Products Advisory Committee November 8, 2019 Meeting Announcement - 11/08/2019 - 11/08/2019

This is the CBER Vaccines and Related Biological Products Advisory Committee November 8, 2019 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/347PLQt

January 07, 2022 at 08:16PM Vaccines and Related Biological Products Advisory Committee March 6 - 7, 2019 Meeting Announcement - 03/06/2019 - 03/07/2019

This is the CBER Vaccines and Related Biological Products Advisory Committee March 6 - 7, 2019 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JyZQwj

January 07, 2022 at 05:57PM Biologics Electronic Reading Room (eFOI)

The Biologics eFOI Reading Room provides access to documents posted throughout the "Vaccines, Blood & Biologics" and other sections related to the Center for Biologics Evaluation and Research on the FDA.gov Web site.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/39uWism

January 07, 2022 at 02:59PM Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months

The FDA amended the emergency use authorization (EUA) for the Moderna COVID-19 Vaccine to shorten the time between the completion of a primary series of the vaccine and a booster dose to at least five months for individuals 18 years of age and older.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3GaiZkj

January 06, 2022 at 09:01PM Allergenic Products Advisory Committee September 13, 2019 Meeting Announcement - 09/13/2019 - 09/13/2019

This is the main page for the Allergenic Products Advisory Committee September 13, 2019 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Jc67xV

January 06, 2022 at 08:22PM Vaccines and Related Biological Products Advisory Committee October 9, 2019 Meeting Announcement - 10/09/2019 - 10/09/2019

This is the CBER Vaccines and Related Biological Products Advisory Committee October 9, 2019 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/34bRILB

Tuesday, January 4, 2022

January 04, 2022 at 04:31PM International Activities

CBER’s international activities can be categorized in the following functional areas: regulatory harmonization, regulatory capacity building, information sharing, international standards setting, and collaborative research.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32D34XF

Monday, January 3, 2022

January 03, 2022 at 03:34PM Global Unique Device Identification Database (GUDID)

Provides information necessary for submitting data to the Global Unique Device Identification Database (GUDID). Primarily intended for device labelers.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3hHbrdL

January 03, 2022 at 03:31PM Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine

The FDA amended the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to take several actions that will expand the use of the vaccine in certain populations.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3eKvabp

January 03, 2022 at 02:15PM Charter of the Vaccines and Related Biological Products Advisory Committee

This is the Charter of the Vaccines and Related Biological Products Advisory Committee.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3a6ZgCw

January 02, 2022 at 10:31PM FDA Voices on Medical Products

FDA Voices on Medical Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3fPjV0W

January 02, 2022 at 10:26PM FDA Voices on Policy

FDA Voices on Policy

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2wZLu61

January 02, 2022 at 09:34PM FDA Voices

Insights from FDA leadership and experts into the agency's work on policy, consumer safety & enforcement, medical products, food, & tobacco.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3eLllbZ